Irrcs Instituto Clinico Humanitas

Rozzano 20089

0 studies enrolling now · 4 studies all time

What they study most

Chronic Graft-versus-host Disease, Head and Neck Cancer, Metastatic Urothelial Carcinoma, Solid Tumors, Unresectable Urothelial Carcinoma

Studies at this site

• Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) — Completed
• Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205) — Stopped early
• GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Stopped early
• A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors — Completed